Company Filing History:
3 out of 541 
2 out of 6 Years Active: 2021-2025
Title: The Innovations of Isabelle Sermadiras
Introduction
Isabelle Sermadiras is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic polypeptides. With a total of 4 patents to her name, her work focuses on innovative solutions for cardiovascular diseases.
Latest Patents
Isabelle's latest patents include groundbreaking inventions related to heterodimeric Relaxin fusion polypeptides. The first patent, titled "Heterodimeric Relaxin fusions and uses thereof," describes the development of heterodimeric Relaxin 2 fusion polypeptides. This invention provides various applications, including nucleic acid molecules, vectors, host cells, pharmaceutical compositions, and kits. These innovations are particularly aimed at treating cardiovascular diseases, such as heart failure.
Another significant patent is "Relaxin fusion polypeptides and uses thereof," which also focuses on Relaxin 2 fusion polypeptides. Similar to her previous work, this invention encompasses a range of applications, including methods of treatment for cardiovascular conditions. The polypeptides and compositions developed through her research hold promise for improving patient outcomes in heart failure treatment.
Career Highlights
Throughout her career, Isabelle has worked with notable companies, including Medimmune Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Isabelle has collaborated with esteemed colleagues such as Monika Anna Papworth and Judy Christiane Paterson. These partnerships have further enriched her research and innovation efforts.
Conclusion
Isabelle Sermadiras is a trailblazer in the field of biomedical innovation, with a focus on developing therapeutic solutions for cardiovascular diseases. Her patents and collaborations reflect her commitment to advancing medical science and improving patient care.